ArticleMolecules (Basel, Switzerland)2026

Combining Temozolomide with a Selective CK2 Inhibitor Results in Anti-Tumour Effects in Glioblastoma Cell Lines.

Anne S Boewe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.